Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in Florida
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Florida
| Provider | Medicare | Services |
|---|---|---|
| Quest Diagnostics Clinical... | $172.03 | 429 |
| Quest Diagnostics Clinical... | $171.77 | 110 |
| Laboratory Corporation Of America | $172.12 | 58 |
Florida Pricing in Context
In Florida, CPT code 0014M (Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test)) carries an average Medicare payment of $171.99 — 0% below the national benchmark of $172.16. 4 providers across the state submitted claims for this procedure in 2023, performing 598 total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Florida is $429.41, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Other procedures, the estimated commercial insurance price in Florida lands near $404.18, with self-pay cash prices typically around $247.08. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) cost in Florida?
The average Medicare payment for Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in Florida is $171.99, which is 0% below the national average of $172.16. Providers in FL typically bill $429.41 for this procedure.
What does Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) cost with insurance in Florida?
With commercial insurance in Florida, Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) costs an estimated $404.18. Without insurance, the estimated cash price is $247.08. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in Florida?
4 providers in Florida billed Medicare for Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in 2023, performing 598 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) cheaper in Florida than the national average?
Yes — Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) costs 0% below the national average in Florida. The state average Medicare payment is $171.99 compared to $172.16 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.